<p>(A,B) Binding of the indicated ligands to the HIV-1<sub>JR-FL</sub> Env(-)Δ808-NDs that had been incubated at room temperature for a week is compared to that of the same ligands to glutaraldehyde-treated and untreated HIV-1<sub>JR-FL</sub> Env(-)Δ808 glycoprotein on the surface of expressing cells. Shading of the ligands is described in the legend to <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0170672#pone.0170672.g006" target="_blank">Fig 6</a>. (<b>C</b>) The binding of the indicated ligands to the HIV-1<sub>JR-FL</sub> Env(-)Δ808 E168K-NDs that had been incubated at room temperature for one week is shown. The E168K change allows the HIV-1<sub>JR-FL</sub> Env to be recognized by the V2 quaternary-dependent ant...
<p>The binding of each of the indicated ligands to the HIV-1<sub>BG505</sub> ΔCT Env variants expres...
(A) Binding to 293T cells transfected with an empty pcDNA3.1 plasmid or increasing concentrations of...
Neutralization of human immunodeficiency virus type 1 by adding antibody after the virus has attache...
<p>(A-D) The binding of the indicated ligands to the HIV-1<sub>JR-FL</sub> Env(-)Δ808 glycoprotein i...
<p>(A) The epitopes on the HIV-1 Env trimer recognized by the monoclonal antibodies used in this stu...
<p>HIV-1 PSVs on a pSG3Δenv backbone and bearing Env from strains ADA or JR-CSF, were concentrated (...
<p>(<b>A</b>) BN-PAGE analysis of the thermostability of wildtype HIV-1<sub>LAI-JR-FL</sub> and SOS-...
1<p>T<sub>90</sub>, the temperature at which HIV-1 infectivity decreases by 90% in 1 h, and the stan...
<p>The binding of PGT121 (<b>A</b>) and PG9 (<b>B</b> and <b>C</b>) to HIV-1<sub>BG505</sub> Env ΔCT...
<p>(A) Microscale thermophoresis profiles of the interaction of the 2G12 and 4E10 antibodies with HI...
Envelope glycoprotein (Env) reactivity (ER) describes the propensity of human immunodeficiency virus...
<p>(<b>A</b>) HIV-1<sub>LAI-JR2</sub> MC, produced in 293T cells, was incubated for various time int...
The HIV-1 envelope glycoprotein (Env) spike is challenging to study at the molecular level, due in p...
<p>HIV-1 LAI-chimeric MCs bearing Envs of JR-CSF (top), JR-FL (middle) and ADA (bottom) were treated...
The HIV-1 envelope glycoprotein (Env) spike is challenging to study at the molecular level, due in p...
<p>The binding of each of the indicated ligands to the HIV-1<sub>BG505</sub> ΔCT Env variants expres...
(A) Binding to 293T cells transfected with an empty pcDNA3.1 plasmid or increasing concentrations of...
Neutralization of human immunodeficiency virus type 1 by adding antibody after the virus has attache...
<p>(A-D) The binding of the indicated ligands to the HIV-1<sub>JR-FL</sub> Env(-)Δ808 glycoprotein i...
<p>(A) The epitopes on the HIV-1 Env trimer recognized by the monoclonal antibodies used in this stu...
<p>HIV-1 PSVs on a pSG3Δenv backbone and bearing Env from strains ADA or JR-CSF, were concentrated (...
<p>(<b>A</b>) BN-PAGE analysis of the thermostability of wildtype HIV-1<sub>LAI-JR-FL</sub> and SOS-...
1<p>T<sub>90</sub>, the temperature at which HIV-1 infectivity decreases by 90% in 1 h, and the stan...
<p>The binding of PGT121 (<b>A</b>) and PG9 (<b>B</b> and <b>C</b>) to HIV-1<sub>BG505</sub> Env ΔCT...
<p>(A) Microscale thermophoresis profiles of the interaction of the 2G12 and 4E10 antibodies with HI...
Envelope glycoprotein (Env) reactivity (ER) describes the propensity of human immunodeficiency virus...
<p>(<b>A</b>) HIV-1<sub>LAI-JR2</sub> MC, produced in 293T cells, was incubated for various time int...
The HIV-1 envelope glycoprotein (Env) spike is challenging to study at the molecular level, due in p...
<p>HIV-1 LAI-chimeric MCs bearing Envs of JR-CSF (top), JR-FL (middle) and ADA (bottom) were treated...
The HIV-1 envelope glycoprotein (Env) spike is challenging to study at the molecular level, due in p...
<p>The binding of each of the indicated ligands to the HIV-1<sub>BG505</sub> ΔCT Env variants expres...
(A) Binding to 293T cells transfected with an empty pcDNA3.1 plasmid or increasing concentrations of...
Neutralization of human immunodeficiency virus type 1 by adding antibody after the virus has attache...